Amy E. Hulme

1.7k total citations
22 papers, 1.2k citations indexed

About

Amy E. Hulme is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Amy E. Hulme has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Virology and 6 papers in Infectious Diseases. Recurrent topics in Amy E. Hulme's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and Ion channel regulation and function (3 papers). Amy E. Hulme is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (6 papers) and Ion channel regulation and function (3 papers). Amy E. Hulme collaborates with scholars based in United States, Australia and Japan. Amy E. Hulme's co-authors include Thomas J. Hope, John V. Moran, Hal P. Bogerd, Bryan R. Cullen, Omar Perez, José L. García-Pérez, Heather L. Wiegand, Katherine O’Shea, Deirdre Foley and Mirella Dottori and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Amy E. Hulme

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Hulme United States 12 737 526 351 274 230 22 1.2k
Maria Zhadina United States 7 532 0.7× 356 0.7× 73 0.2× 176 0.6× 249 1.1× 7 1.0k
Deanna A. Kulpa United States 21 910 1.2× 607 1.2× 652 1.9× 388 1.4× 170 0.7× 32 1.9k
Rafal Kaminski United States 18 1.2k 1.6× 497 0.9× 103 0.3× 196 0.7× 240 1.0× 36 1.6k
Zehua Feng United States 15 647 0.9× 595 1.1× 69 0.2× 105 0.4× 450 2.0× 29 982
Renée N. Douville Canada 16 505 0.7× 145 0.3× 329 0.9× 102 0.4× 119 0.5× 32 1.1k
Dimiter Demirov United States 12 461 0.6× 721 1.4× 43 0.1× 351 1.3× 304 1.3× 16 1.2k
Landon L. Moore United States 15 770 1.0× 81 0.2× 316 0.9× 104 0.4× 180 0.8× 23 1.2k
Suraj Saksena United States 15 999 1.4× 70 0.1× 80 0.2× 167 0.6× 168 0.7× 20 1.7k
Laura Doglio United Kingdom 11 332 0.5× 177 0.3× 110 0.3× 45 0.2× 126 0.5× 18 643
Jessica Otte United States 17 449 0.6× 95 0.2× 97 0.3× 80 0.3× 116 0.5× 29 1.2k

Countries citing papers authored by Amy E. Hulme

Since Specialization
Citations

This map shows the geographic impact of Amy E. Hulme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Hulme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Hulme more than expected).

Fields of papers citing papers by Amy E. Hulme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Hulme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Hulme. The network helps show where Amy E. Hulme may publish in the future.

Co-authorship network of co-authors of Amy E. Hulme

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Hulme. A scholar is included among the top collaborators of Amy E. Hulme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Hulme. Amy E. Hulme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finol‐Urdaneta, Rocio K., Amy E. Hulme, Mauricio Castro Cabral-da-Silva, et al.. (2024). Alzheimer’s disease induced neurons bearing PSEN1 mutations exhibit reduced excitability. Frontiers in Cellular Neuroscience. 18. 1406970–1406970. 3 indexed citations
2.
Chakrabarti, Sampurna, Mohammed A. Khallaf, Amy E. Hulme, et al.. (2024). Touch sensation requires the mechanically gated ion channel ELKIN1. Science. 383(6686). 992–998. 13 indexed citations
3.
Hulme, Amy E., et al.. (2024). Parsing the effect of co-culture with brain organoids on Diffuse Intrinsic Pontine Glioma (DIPG) using quantitative proteomics. The International Journal of Biochemistry & Cell Biology. 174. 106617–106617. 2 indexed citations
4.
Hulme, Amy E., Martin Engel, Sonia Sanz Muñoz, et al.. (2024). REST and RCOR genes display distinct expression profiles in neurons and astrocytes using 2D and 3D human pluripotent stem cell models. Heliyon. 10(12). e32680–e32680. 2 indexed citations
5.
Corben, Louise A., Amy E. Hulme, Mirella Dottori, et al.. (2024). Omaveloxolone for the Treatment of Friedreich Ataxia: Efficacy, Safety, and Future Perspectives. Movement Disorders. 40(2). 226–230. 3 indexed citations
6.
Hulme, Amy E., et al.. (2021). Making neurons, made easy: The use of Neurogenin-2 in neuronal differentiation. Stem Cell Reports. 17(1). 14–34. 63 indexed citations
7.
Hulme, Amy E., Andrew E. Tee, Jane Sun, et al.. (2021). The RNA‐helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma. Molecular Oncology. 15(4). 1162–1179. 20 indexed citations
8.
Wise, Emma L., et al.. (2021). Overlap Intensity: An ImageJ Macro for Analyzing the HIV-1 In Situ Uncoating Assay. Viruses. 13(8). 1604–1604. 1 indexed citations
9.
Howden, Sara E., et al.. (2020). Particle-mediated delivery of frataxin plasmid to a human sensory neuronal model of Friedreich's ataxia. Biomaterials Science. 8(9). 2398–2403. 6 indexed citations
10.
Martin, Richard, et al.. (2020). Characterization of HIV-1 uncoating in human microglial cell lines. Virology Journal. 17(1). 31–31. 18 indexed citations
11.
Hulme, Amy E., Jeffrey R. McArthur, Lezanne Ooi, et al.. (2020). Molecular and Functional Characterization of Neurogenin-2 Induced Human Sensory Neurons. Frontiers in Cellular Neuroscience. 14. 600895–600895. 23 indexed citations
12.
Engel, Martin, Alan T. Maccarone, Benjamin Heng, et al.. (2018). Novel dual‐action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine‐specific histone demethylase 1A inhibitor. Journal of Neurochemistry. 149(4). 535–550. 11 indexed citations
13.
Takeda, Eri, Ken Kono, Amy E. Hulme, et al.. (2015). Fluorescent Image Analysis of HIV-1 and HIV-2 Uncoating Kinetics in the Presence of Old World Monkey TRIM5α. PLoS ONE. 10(3). e0121199–e0121199. 7 indexed citations
14.
Hulme, Amy E., et al.. (2015). Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells. Journal of Virology. 89(10). 5350–5361. 86 indexed citations
15.
Hulme, Amy E., et al.. (2014). Identification of Capsid Mutations That Alter the Rate of HIV-1 Uncoating in Infected Cells. Journal of Virology. 89(1). 643–651. 53 indexed citations
16.
Kono, Ken, Eri Takeda, Amy E. Hulme, et al.. (2013). Slower Uncoating Is Associated with Impaired Replicative Capability of Simian-Tropic HIV-1. PLoS ONE. 8(8). e72531–e72531. 6 indexed citations
17.
Hulme, Amy E. & Thomas J. Hope. (2013). The Cyclosporin A Washout Assay to Detect HIV-1 Uncoating in Infected Cells. Methods in molecular biology. 1087. 37–46. 22 indexed citations
18.
Doucet, Aurélien J., Amy E. Hulme, Deanna A. Kulpa, et al.. (2010). Characterization of LINE-1 Ribonucleoprotein Particles. PLoS Genetics. 6(10). e1001150–e1001150. 186 indexed citations
19.
Hulme, Amy E., Hal P. Bogerd, Bryan R. Cullen, & John V. Moran. (2006). Selective inhibition of Alu retrotransposition by APOBEC3G. Gene. 390(1-2). 199–205. 128 indexed citations
20.
Bogerd, Hal P., Heather L. Wiegand, Amy E. Hulme, et al.. (2006). Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proceedings of the National Academy of Sciences. 103(23). 8780–8785. 310 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026